TYMS and rectal cancer: Separately, in locally advanced rectal cancer, CTCs expressing thymidylate synthase (TYMS) and RAD23 homolog B (RAD23B) were identified as markers of resistance to chemotherapy and radiotherapy (Figure 2) [75].